Research output per year
Research output per year
Personal profile
Research interests
My primary research interest is to develop and conduct phase I and II clinical trials with novel agents for patients with newly diagnosed or relapsed lung cancer. I am also interested in clinical trial methodology and medical education.
Clinical interests
Thoracic oncology, lung cancer
Fingerprint
Dive into the research topics where Maria Baggstrom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investing in Women Trainees: Building a Women in Medicine Group at an Academic Institution
Zhong, L., Lee, K., Baggstrom, M. Q. & Bhayani, R. K., 2023, In: Journal of medical Internet research. 25, e47783.Research output: Contribution to journal › Review article › peer-review
Open Access -
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Bagegni, N. A., Park, H., Kraft, K., O-Toole, M., Gao, F., Waqar, S. N., Ratner, L., Morgensztern, D., Devarakonda, S., Amin, M., Baggstrom, M. Q., Liang, C., Selvaggi, G. & Wang-Gillam, A., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 487-497 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer
Contreras, J., Srivastava, A., Samson, P., DeWees, T., Govindan, R., Baggstrom, M. Q., Morgensztern, D., Roach, M., Badiyan, S. N., Bradley, J., Waqar, S. & Robinson, C., Jul 15 2022, In: International Journal of Radiation Oncology Biology Physics. 113, 4, p. 742-748 7 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
Devarakonda, S., Pellini, B., Verghese, L., Park, H., Morgensztern, D., Govindan, R., Suresh, R., Oppelt, P., Baggstrom, M. Q., Wu, N. & Waqar, S. N., Jul 2021, In: Journal of Thoracic Disease. 13, 7, p. 4054-4062 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies
Lim, K. H., Opyrchal, M., Acharya, A., Boice, N., Wu, N., Gao, F., Webster, J., Lockhart, A. C., Waqar, S. N., Govindan, R., Morgensztern, D., Picus, J., Tan, B. R., Baggstrom, M. Q., Maher, C. A. & Wang-Gillam, A., Sep 2021, In: European Journal of Cancer. 154, p. 102-110 9 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations